170,000 Shares in The Chemours Company $CC Acquired by Annis Gardner Whiting Capital Advisors LLC

Annis Gardner Whiting Capital Advisors LLC acquired a new stake in shares of The Chemours Company (NYSE:CC) in the first quarter, HoldingsChannel reports. The firm acquired 170,000 shares of the specialty chemicals company’s stock, valued at approximately $3,745,000. Chemours comprises 0.6% of Annis Gardner Whiting Capital Advisors LLC’s portfolio, making the stock its 22nd biggest holding.

Other hedge funds also recently bought and sold shares of the company. Baird Financial Group Inc. bought a new stake in Chemours during the 1st quarter valued at about $148,000. Royal Bank of Canada raised its stake in shares of Chemours by 6.8% during the first quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company’s stock valued at $7,926,000 after acquiring an additional 37,382 shares in the last quarter. AQR Capital Management LLC bought a new stake in shares of Chemours during the first quarter valued at approximately $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of Chemours by 149.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company’s stock valued at $593,000 after purchasing an additional 25,899 shares during the period. Finally, Empowered Funds LLC purchased a new position in Chemours during the 1st quarter worth $403,000. Institutional investors own 76.26% of the company’s stock.

Wall Street Analyst Weigh In

CC has been the subject of a number of research analyst reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Chemours in a research report on Monday, April 20th. Mizuho cut their price target on Chemours from $30.00 to $25.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 1st. Zacks Research upgraded Chemours from a “strong sell” rating to a “hold” rating in a report on Friday, April 24th. Morgan Stanley upped their price objective on shares of Chemours from $17.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Monday, May 11th. Finally, JPMorgan Chase & Co. increased their target price on shares of Chemours from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, May 21st. Six research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Chemours currently has an average rating of “Hold” and an average target price of $24.10.

Chemours Trading Up 1.3%

NYSE CC opened at $17.56 on Friday. The Chemours Company has a 52 week low of $10.44 and a 52 week high of $28.67. The company has a 50 day moving average price of $21.05 and a 200 day moving average price of $19.67. The company has a quick ratio of 0.87, a current ratio of 1.82 and a debt-to-equity ratio of 18.98. The firm has a market cap of $2.64 billion, a PE ratio of -6.65 and a beta of 1.41.

Chemours (NYSE:CC) last announced its earnings results on Tuesday, May 5th. The specialty chemicals company reported $0.05 earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.10. Chemours had a negative net margin of 6.82% and a positive return on equity of 52.49%. The company had revenue of $1.38 billion during the quarter, compared to the consensus estimate of $1.40 billion. During the same period last year, the firm earned $0.13 earnings per share. Chemours’s revenue was up 1.0% compared to the same quarter last year. As a group, sell-side analysts forecast that The Chemours Company will post 1.16 EPS for the current fiscal year.

Chemours Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Stockholders of record on Sunday, May 17th were given a $0.0875 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 2.0%. Chemours’s dividend payout ratio (DPR) is presently -13.26%.

Chemours Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.